Total cost of different lines of treatment for diffuse large B-cell lymphoma in Denmark – analysis of real data. Health Economics October 14, 2025 byhealthnova0
Cost-effectiveness thresholds under political pressure: Where are the health economists? Health Economics October 14, 2025 byhealthnova0
Total cost of different lines of treatment for diffuse large B-cell lymphoma in Denmark – analysis of real data. Health Economics October 14, 2025 byhealthnova0
Cost-effectiveness thresholds under political pressure: Where are the health economists? Health Economics October 14, 2025 byhealthnova0
Total cost of different lines of treatment for diffuse large B-cell lymphoma in Denmark – analysis of real data. Health Economics October 14, 2025 byhealthnova0
Cost-effectiveness thresholds under political pressure: Where are the health economists? Health Economics October 14, 2025 byhealthnova0
EQ-5D-5L and SF-6DV2 utility comparison of blood cancer patients with QLU-C10D utility comparison Health Economics August 20, 2025 byhealthnova0
In patients with gastric cancer, the EQ-5D-5L and QLU-C10D utility verification in the method and the results related to the analysis of the results Health Economics July 31, 2025 byhealthnova0
Testist reliability for online extraction of personal utility function (OPUF) approach to evaluate EQ-HWB-S Health Economics March 29, 2025 byhealthnova0
